Raising a Series C+? Cathy Gao’s bringing the real playbook to TechCrunch All Stage

Sapphire Ventures Partner Cathy Gao will present at TechCrunch All Stage 2025 on July 15, discussing the evolving landscape of growth-stage fundraising, particularly Series C and beyond. Gao's session will focus on how GenAI is influencing later-stage funding, what investors are seeking in deals, and strategies for founders raising $30M or more in today's competitive market, offering insights for scaling AI companies and navigating the current fundraising environment.

Analysis

The article indicates a shift in the dynamics of growth-stage fundraising, particularly for Series C rounds and beyond, with Sapphire Ventures Partner Cathy Gao scheduled to detail these changes at TechCrunch All Stage 2025. A central theme is the impact of Generative AI, which is described as fueling a resurgence in later-stage investment while also presenting challenges for founders in articulating their value proposition effectively in an increasingly competitive market. The discussion will reportedly focus on revised investor expectations for deals, especially those in the $30 million-plus range, implying a need for founders to refine their pitches and strategies. The overall sentiment of the provided signals is moderately positive, likely reflecting the opportunities presented by GenAI-driven funding, though the low market impact score suggests the article's content is more indicative of evolving industry trends rather than immediate, direct market-moving events for specific public equities.

Key Decisions for Investors

• Investors focused on late-stage venture capital should anticipate evolving due diligence criteria and valuation sensitivities, particularly concerning the tangible application and scalability of GenAI within target companies.
• Monitor takeaways from industry conferences like TechCrunch All Stage for early insights into changing investor preferences, deal structures, and key metrics being prioritized in the current growth-stage fundraising environment, especially for substantial rounds exceeding $30M.
• Critically evaluate how effectively potential and existing portfolio companies are integrating and articulating their GenAI strategies, as the fundraising landscape appears to be penalizing superficial or poorly communicated approaches despite the technology's perceived potential.